研究業績
2022年
Original Article
Kawashima Y, Fukuhara T, Saito H, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Seike M, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M.: Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer. Tanimura K, Yamada T, Okada K, Nakai K, Horinaka M, Katayama Y, Morimoto K, Ogura Y, Takeda T, Shiotsu S, Ichikawa K, Watanabe S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Taniguchi H, Yoneda K, Matoba S, Sakai T, Uehara H, Yano S, Kusaba T, Katayama R, Takayama K.: HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features. Yanagimura N, Takeuchi S, Fukuda K, Arai S, Tanimoto A, Nishiyama A, Ogo N, Takahashi H, Asai A, Watanabe S, Kikuchi T, Yano S.: STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis. Ichikawa K, Watanabe S, Miura S, Ohtsubo A, Shoji S, Nozaki K, Tanaka T, Saida Y, Kondo R, Hokari S, Aoki N, Ohshima Y, Koya T, Kikuchi T.: Prognostic significance of procalcitonin in small cell lung cancer. Oizumi S, Takamura K, Harada T, Tachihara M, Morikawa N, Honda R, Watanabe S, Asao T, Kunisaki M, Fukuhara T, Noro R, Kikuchi E, Tsutani Y, Tenma T, Kobayashi K, Dosaka-Akita H.: Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024. Shima K, Arumugam P, Sallese A, Horia Y, Ma Y, Trapnell C, Wessendarp M, Chalk C, McCarthy C, Carey BC, Trapnell BC, Suzuki T.: A Murine Model of Hereditary Pulmonary Alveolar Proteinosis Caused by Homozygous Csf2ra Gene Disruption Koyama K, Miura S, Watanabe S, Shoji S, Koshio J, Hayashi Y, Ishikawa D, Sato K, Miyabayashi T, Okajima M, Ota T, Tanaka T, Matsumoto N, Kuriyama H, Abe T, Nozaki K, Ichikawa K, Kondo R, Tanaka H, Kikuchi T.: Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC. Okano H, Sakuraya M, Masuyama T, Kimata S, Hokari S.: Respiratory support strategy in adults with acute hypoxemic respiratory failure: a systematic review and network meta-analysis. Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota JI, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A.: Clinical manifestations of hospitalized influenza patients without risk factors: A prospective multicenter cohort study in Japan via internet surveillance. Takahashi M, Watanabe S, Suzuki R, Arita M, Sato K, Sato M, Sekiya Y, Abe Y, Fujisaki T, Ohtsubo A, Shoji S, Nozaki K, Ichikawa K, Kondo R, Saida Y, Hokari S, Aoki N, Hayashi M, Ohshima Y, Koya T, Kikuchi T.: PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer. Cao S, Zhang Y, Zhou Y, Rong W, Wang Y, Ling X, Zhang L, Li J, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Dermime S, Zhong R, Zhong H.: A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer. He BX, Zhong YF, Zhu YB, Deng JJ, Fang MJ, She YL, Wang TT, Yang Y, Sun XW, Belluomini L, Watanabe S, Dong D, Tian J, Xie D.: Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk. Tasaka S, Ohshimo S, Takeuchi M, Yasuda H, Ichikado K, Tsushima K, Egi M, Hashimoto S, Shime N, Saito O, Matsumoto S, Nango E, Okada Y, Hayashi K, Sakuraya M, Nakajima M, Okamori S, Miura S, Fukuda T, Ishihara T, Kamo T, Yatabe T, Norisue Y, Aoki Y, Iizuka Y, Kondo Y, Narita C, Kawakami D, Okano H, Takeshita J, Anan K, Okazaki SR, Taito S, Hayashi T, Mayumi T, Terayama T, Kubota Y, Abe Y, Iwasaki Y, Kishihara Y, Kataoka J, Nishimura T, Yonekura H, Ando K, Yoshida T, Masuyama T, Sanui M; ARDS Clinical Practice Guideline 2021 committee from the Japanese Society of Intensive Care Medicine, the Japanese Respiratory Society, and the Japanese Society of Respiratory Care Medicine.: ARDS Clinical Practice Guideline 2021. Tasaka S, Ohshimo S, Takeuchi M, Yasuda H, Ichikado K, Tsushima K, Egi M, Hashimoto S, Shime N, Saito O, Matsumoto S, Nango E, Okada Y, Hayashi K, Sakuraya M, Nakajima M, Okamori S, Miura S, Fukuda T, Ishihara T, Kamo T, Yatabe T, Norisue Y, Aoki Y, Iizuka Y, Kondo Y, Narita C, Kawakami D, Okano H, Takeshita J, Anan K, Okazaki SR, Taito S, Hayashi T, Mayumi T, Terayama T, Kubota Y, Abe Y, Iwasaki Y, Kishihara Y, Kataoka J, Nishimura T, Yonekura H, Ando K, Yoshida T, Masuyama T, Sanui M; ARDS Clinical Practice Guideline Committee 2021 from the Japanese Respiratory Society, the Japanese Society of Intensive Care Medicine, and the Japanese Society of Respiratory Care Medicine.: ARDS clinical practice guideline 2021 Ohashi K, Ito R, Koda R, Iino N, Takada T.: Serum cytokine changes induced by direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute respiratory failure Yamaguchi O, Kaira K, Naruse I, Umeda Y, Honda T, Watanabe S, Ichikawa K, Tateishi K, Kasahara N, Higuchi T, Hashimoto K, Shinomiya S, Miura Y, Shiono A, Mouri A, Imai H, Iizuka K, Ishizuka T, Minato K, Suda S, Kagamu H, Mori K, Kuji I, Seki N.: Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer. Ozawa M, Nakajima S, Kobayashi D, Tomii K, Li NJ, Watarai T, Suzuki R, Watanabe S, Kanda Y, Takeuchi A, Katakai T: Micro- and Macro-Anatomical Frameworks of Lymph Nodes Indispensable for the Lymphatic System Filtering Function Hotta K, Hida T, Nokihara H, Morise M, Kim YH, Azuma K, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Watanabe S, Goto K, Satouchi M, Kozuki T, Shukuya T, Nakagawa K, Mitsudomi T, Yamamoto N, Asakawa T, Yoshimoto T, Takata S, Tamura T.: Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer. Seki T, Saida Y, Kishimoto S, Lee J, Otowa Y, Yamamoto K, Chandramouli GV, Devasahayam N, Mitchell JB, Krishna MC, Brender JR: PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study Miyashita N, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Kiyota H, Watanabe A.: Usefulness of the Legionella Score for differentiating from COVID-19 pneumonia to legionella pneumonia. Abe T, Hakamata M, Nishiyama A, Tateishi Y, Matsumoto S, Hemmi H, Ueda D, Sato T.: Identification and functional analysis of a new type of Z,E-mixed prenyl reductase from mycobacteria Nishiyama Y, Koya T, Nagano K, Abe S, Kimura Y, Shima K, Toyama-Kosaka M, Hasegawa T, Sasaki T, Shinbori K, Ueki S, Takamura K, Kikuchi T.: Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology? Shoji S, Miura S, Watanabe S, Ohtsubo A, Nozaki K, Saida Y, Ichikawa K, Kondo R, Tanaka T, Koyama K, Tanaka H, Okajima M, Abe T, Ota T, Ishida T, Makino M, Iwashima A, Sato K, Matsumoto N, Yoshizawa H, Kikuchi T.: Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302). Kushiro K, Watanabe S, Goto Y, Fujisaki T, Yanagimura N, Ohtsubo A, Shoji S, Nozaki K, Tanaka T, Saida Y, Sato Y, Ota T, Koshio J, Hayashi Y, Miyabayashi T, Matsumoto N, Ichikawa K, Koyama K, Kikuchi T.: Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients. Ogata H, Aoki N, Nagano K, Hakamata M, Bamba Y, Shibata S, Koizumi T, Ohshima Y, Watanabe S, Moro H, Koya T, Kikuchi T.: Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study. Koya T, Sakai N, Sasaki T, Shinbori K, Nagai A, Kimura Y, Toyama M, Hayashi M, Saito A, Nishiyama Y, Hasegawa T, Muramatsu Y, Muramatsu K, Horii A, Kikuchi T.: Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population. Nagano K, Kawasaki S, Moro H, Chang B, Bamba Y, Yamamoto A, Morita M, Ohnishi M, Shibata S, Koizumi T, Aoki N, Honma Y, Abe T, Koya T, Aoki N, Kikuchi T.: An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan. Asao T, Watanabe S, Tanaka T, Morita S, Kobayashi K.: A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol. Watanabe S, Sakai K, Matsumoto N, Koshio J, Ishida A, Abe T, Ishikawa D, Tanaka T, Aoki A, Kajiwara T, Koyama K, Miura S, Goto Y, Sekiya T, Suzuki R, Kushiro K, Fujisaki T, Yanagimura N, Ohtsubo A, Shoji S, Nozaki K, Saida Y, Yoshizawa H, Nishio K, Kikuchi T.: Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)
Case Report
Nozaki K, Watanabe S, Nishio K, Sakai K, Kikuchi T: Effectiveness of afatinib in an NSCLC patient with EGFR mutation and early progression to osimertinib: a case report Nishiyama Y, Koya T, Nagano K, Abe S, Kimura Y, Shima K, Toyama-Kosaka M, Hasegawa T, Sasaki T, Shinbori K, Ueki S, Takamura K, Kikuchi T.: Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology? Aoki A, Saito A, Shima K, Kimura Y, Asakawa K, Ohashi R, Umezu H, Sakagami T, Moriyama H, Kikuchi T.: Occupational Lung Disease Caused by Exposure to Polytetrafluoroethylene Shoji S, Watanabe S, Hanazawa Y, Fujisaki T, Kikuchi T.: Three non-small cell lung cancer patients who developed pulmonary thromboses during osimertinib treatment and could safely resume concomitant anticoagulation treatment: a report of three cases
Review
Letter/Correspondence
和文総説
村井裕衣、小屋俊之、菊地利明: 生物学的製剤：デュピルマブ奈良本駿、小屋俊之、長谷川隆志、木村陽介、島賢治郎、青木亜美、林正周、酒井菜摘、田中健太郎、坪川史人、筒井裕一、新堀香織、佐々木崇暢、堀井新、村松芳幸、真島一郎、村松公美子、菊池利明: Dupilumab導入によるうつ症状への影響田中知宏、三浦理: がん腫に関係なくTMB-HighはPD-1/PD-L1阻害薬のバイオマーカーとなりうるか KEYNOTE-158試験の結果からの考察
受賞・表彰
渡部聡: 新潟県医師会学術奨励賞森谷梨加: 第59回睡眠呼吸障害研究会優秀賞渡辺裕介（指導：穂苅諭）: 医学生・研修医の日本内科学会ことはじめ2022 京都 優秀演題賞早福はるか: 第62回日本呼吸器学会学術講演会 呼吸器病学ことはじめ アナライザーセッション優秀賞才田優: 第26回有壬記念学術奨励賞才田優: 第9回学長賞（若手教員研究奨励）森谷梨加: 第31回PneumoForum 優秀賞宮加谷昌紀（指導：穂苅諭）: 第89回呼吸器合同北陸地方会研修医セッション優秀演題賞柳村尚寛: 日本肺癌学会若手奨励賞才田優: 新潟県医師会学術研究助成金
